Literature DB >> 10853709

Low dose (1 microg) adrenocorticotropin stimulation test in the evaluation of hypothalamo-pituitary-adrenal axis in patients with active pulmonary tuberculosis.

F Keleştimur1, Z Göktaş, I Gülmez, K Unlühizarci, F Bayram, M Ozesmi, M Güven, A Tutuş.   

Abstract

Adrenocortical function in patients with active pulmonary tuberculosis is a debate of matter. Previous studies related to adrenocortical function in patients with active pulmonary tuberculosis demonstrated a high rate of suboptimal cortisol response to standard dose ACTH (250 microg) stimulation test. The aim of this study was to assess the hypothalamo-pituitary-adrenal (HPA) axis in low dose (1 microg) and standard dose ACTH (250 microg) stimulation tests in the patients with active pulmonary tuberculosis. Twenty-seven patients and 21 healthy subjects were included in the study. Cortisol levels were measured before, 30 and 60 min after ACTH (1 microg or 250 microg iv) injection. Cortisol responses to 1 microg ACTH at 30 and 60 min were significantly higher in the patient group than in the control group (p<0.05). Peak cortisol levels were significantly higher in the patient group than in the control group after both 1 microg and 250 microg ACTH administration (p<0.05). Cortisol responses to 250 microg ACTH at 30 and (at 30 and 60) 60 min were significantly higher in the patient group than in the control group (p<0.05). Peak cortisol levels obtained after 250 microg ACTH and after 1 microg ACTH were similar in the patient group (p>0.05). This study shows that 1 microg ACTH iv gives an equivalent peak cortisol value to 250 microg ACTH in patients with activated HPA axis. The cortisol levels obtained at 08:00, 11:00, 17:00 and 24:00 h were significantly higher in the patients than in the controls. This study clearly shows that HPA axis is activated in active pulmonary tuberculosis rather than underactivated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10853709     DOI: 10.1007/bf03343714

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  18 in total

1.  Adrenocortical function in patients with pulmonary tuberculosis.

Authors:  G R Sarma; C Immanuel; G Ramachandran; P V Krishnamurthy; V Kumaraswami; R Prabhakar
Journal:  Tubercle       Date:  1990-12

2.  Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test.

Authors:  G Dickstein; C Shechner; W E Nicholson; I Rosner; Z Shen-Orr; F Adawi; M Lahav
Journal:  J Clin Endocrinol Metab       Date:  1991-04       Impact factor: 5.958

3.  One microgram is the lowest ACTH dose to cause a maximal cortisol response. There is no diurnal variation of cortisol response to submaximal ACTH stimulation.

Authors:  G Dickstein; D Spigel; E Arad; C Shechner
Journal:  Eur J Endocrinol       Date:  1997-08       Impact factor: 6.664

Review 4.  Clinical review 62: Laboratory assessment of adrenal insufficiency.

Authors:  S K Grinspoon; B M Biller
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958

5.  Rapid adrenocorticotropic hormone test in practice. Retrospective review.

Authors:  M E May; R M Carey
Journal:  Am J Med       Date:  1985-12       Impact factor: 4.965

6.  Changes in the size of adrenal glands in acute pulmonary tuberculosis with therapy.

Authors:  I Gülmez; F Keleştimur; A C Durak; M Ozesmi
Journal:  Endocr J       Date:  1996-10       Impact factor: 2.349

7.  The spectrum of endocrine dysfunction in active pulmonary tuberculosis.

Authors:  F A Post; S G Soule; P A Willcox; N S Levitt
Journal:  Clin Endocrinol (Oxf)       Date:  1994-03       Impact factor: 3.478

8.  Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids.

Authors:  J Broide; R Soferman; S Kivity; A Golander; G Dickstein; Z Spirer; Y Weisman
Journal:  J Clin Endocrinol Metab       Date:  1995-04       Impact factor: 5.958

9.  The role of the low dose (1 microgram) adrenocorticotropin test in the evaluation of patients with pituitary diseases.

Authors:  K Tordjman; A Jaffe; N Grazas; C Apter; N Stern
Journal:  J Clin Endocrinol Metab       Date:  1995-04       Impact factor: 5.958

10.  Adrenal function in patients with active tuberculosis.

Authors:  D J Barnes; S Naraqi; P Temu; J R Turtle
Journal:  Thorax       Date:  1989-05       Impact factor: 9.139

View more
  6 in total

Review 1.  The endocrinology of adrenal tuberculosis: the effects of tuberculosis on the hypothalamo-pituitary-adrenal axis and adrenocortical function.

Authors:  F Kelestimur
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

Review 2.  Endocrine and Metabolic Aspects of Tuberculosis.

Authors:  Christopher Vinnard; Emily A Blumberg
Journal:  Microbiol Spectr       Date:  2017-01

Review 3.  Immunoendocrine interactions during HIV-TB coinfection: implications for the design of new adjuvant therapies.

Authors:  Guadalupe Veronica Suarez; Maria Belen Vecchione; Matias Tomas Angerami; Omar Sued; Andrea Claudia Bruttomesso; Oscar Adelmo Bottasso; Maria Florencia Quiroga
Journal:  Biomed Res Int       Date:  2015-05-14       Impact factor: 3.411

Review 4.  Tuberculosis of the adrenal gland: a case report and review of the literature of infections of the adrenal gland.

Authors:  Jagriti Upadhyay; Praveen Sudhindra; George Abraham; Nitin Trivedi
Journal:  Int J Endocrinol       Date:  2014-08-06       Impact factor: 3.257

5.  Multidrug-Resistant Tuberculosis and Its Association with Adrenal Insufficiency: Assessment with the Low-Dose ACTH Stimulation Test.

Authors:  René Rodríguez-Gutiérrez; Adrian Rendon; Maximiliano Barrera-Sánchez; Kevin Erick Gabriel Carlos-Reyna; Neri Alejandro Álvarez-Villalobos; Gloria González-Saldivar; José Gerardo González-González
Journal:  Int J Endocrinol       Date:  2016-02-23       Impact factor: 3.257

Review 6.  Tuberculosis, the Disrupted Immune-Endocrine Response and the Potential Thymic Repercussion As a Contributing Factor to Disease Physiopathology.

Authors:  Luciano D'Attilio; Natalia Santucci; Bettina Bongiovanni; María L Bay; Oscar Bottasso
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-01       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.